A new laboratory designed to advance early-stage research into lifesaving, commercially viable therapies was celebrated on the USC Health Sciences Campus Tuesday night.
Housed at the USC Norris Comprehensive Cancer Center, the USC/CHLA cGMP Laboratory will manufacture cell and gene therapies under the Food and Drug Administration’s good manufacturing practice (cGMP) standards.
Therapies developed in the lab could one day be used to treat diseases such as arthritis, blindness, cancer and diabetes.
To read more, visit https://stemcell.keck.usc.edu/new-usc-chla-cgmp-lab-opens-to-accelerate-next-generation-cell-therapy.